Incidence and risk factors of communication, swallowing, and orofacial myofunctional disorders in children and adolescents with cancer and benign neoplasms.


Journal

Journal of pediatric rehabilitation medicine
ISSN: 1875-8894
Titre abrégé: J Pediatr Rehabil Med
Pays: Netherlands
ID NLM: 101490944

Informations de publication

Date de publication:
2020
Historique:
pubmed: 17 3 2020
medline: 29 6 2021
entrez: 17 3 2020
Statut: ppublish

Résumé

To describe the incidence and risk factors of communication, swallowing, and orofacial myofunctional disorders in a cohort of children and adolescents with cancer and benign neoplasms. A prospective cohort study conducted with children aged ⩾ 2 years and adolescents of both genders admitted at the Pediatric Oncology Department of the Instituto Nacional de Câncer (INCA) between March 2014 and April 2015. Study participants were submitted to a Speech-Language Pathology (SLP) assessment at three different times: (T1) at hospital admission; (T2) six months after admission; (T3) one year after admission. One hundred and sixty individuals were evaluated. At the time of hospital admission, 68 individuals (42.5%) presented with some type of SLP disorder. After one year of follow-up, 22.8% of the patients had developed new impairments. The occurrence of new speech-language disorders had a statistically significant association with the tumor site. In the risk analysis for the development of speech-language disorders with respect to the primary tumor site, compared to other sites, the central nervous system (CNS) tumor group was 8.29 times more likely to present some new alterations, while the head and neck (HN) tumor group had a 10.36-fold higher risk. An incidence of 22.8% for communication, swallowing, and orofacial myofunctional disorders was observed. The development of these disorders was greater in individuals with tumors in the CNS and in the HN region.

Identifiants

pubmed: 32176665
pii: PRM180576
doi: 10.3233/PRM-180576
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-35

Auteurs

Kaliani Lima Coça (KL)

Section of Speech-Language Pathology, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.

Anke Bergmann (A)

Molecular Carcinogenesis Program, Instituto Nacional do Câncer, Rio de Janeiro, Brazil.

Elisabete Carrara de Angelis (EC)

Section of Speech-Language Pathology, Hospital A.C. Camargo, São Paulo, Brazil.

Sima Ferman (S)

Pediatric Oncology Service, Instituto Nacional do Câncer, Rio de Janeiro, Brazil.

Márcia Gonçalves Ribeiro (MG)

Department of Pediatrics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH